Januszewski AS - Search Results

1

Applications of SGLT2 inhibitors beyond glycaemic control.

O'Hara DV, Lam CSP, McMurray JJV, Yi TW, Hocking S, Dawson J, Raichand S, Januszewski AS, Jardine MJ. O'Hara DV, et al. Among authors: januszewski as. Nat Rev Nephrol. 2024 Aug;20(8):513-529. doi: 10.1038/s41581-024-00836-y. Epub 2024 Apr 26. Nat Rev Nephrol. 2024. PMID: 38671190 Review.

2

Lipid-derived modifications of plasma proteins in experimental and human diabetes.

Januszewski AS, Jenkins AJ, Baynes JW, Thorpe SR. Januszewski AS, et al. Ann N Y Acad Sci. 2005 Jun;1043:404-12. doi: 10.1196/annals.1333.047. Ann N Y Acad Sci. 2005. PMID: 16037262

3

[Somatomedins--structure, mechanism of action and clinical significance].

Zdrojewicz Z, Tokarzewski G, Januszewski A. Zdrojewicz Z, et al. Pol Arch Med Wewn. 1997 Jan;97(1):78-84. Pol Arch Med Wewn. 1997. PMID: 9235558 Review. Polish. No abstract available.

4

[The role of the thymus in the human body].

Zdrojewicz Z, Stadnicka S, Januszewski A. Zdrojewicz Z, et al. Wiad Lek. 1995 Jan-Jun;48(1-12):218-26. Wiad Lek. 1995. PMID: 9638245 Review. Polish.

5

[Activity of converting enzyme angiotensin I to angiotensin II (ACE) in patients with diabetes type II].

Zdrojewicz Z, Januszewski A, Zareba-Bogdał E, Karwacki J, Plamieniak Z. Zdrojewicz Z, et al. Pol Arch Med Wewn. 1995 Apr;93(4):305-13. Pol Arch Med Wewn. 1995. PMID: 7479254 Polish.

6

Diabetes, metabolic disease, and telomere length.

Cheng F, Carroll L, Joglekar MV, Januszewski AS, Wong KK, Hardikar AA, Jenkins AJ, Ma RCW. Cheng F, et al. Among authors: januszewski as. Lancet Diabetes Endocrinol. 2021 Feb;9(2):117-126. doi: 10.1016/S2213-8587(20)30365-X. Epub 2020 Nov 26. Lancet Diabetes Endocrinol. 2021. PMID: 33248477 Review.

7

The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes.

Stitt A, Gardiner TA, Alderson NL, Canning P, Frizzell N, Duffy N, Boyle C, Januszewski AS, Chachich M, Baynes JW, Thorpe SR. Stitt A, et al. Among authors: januszewski as. Diabetes. 2002 Sep;51(9):2826-32. doi: 10.2337/diabetes.51.9.2826. Diabetes. 2002. PMID: 12196477

8

[Evaluation of magnesium, zinc, copper and calcium levels in workers exposed to organic solvents, hydrogen cyanide and harmful physical factors].

Zdrojewicz Z, Koziol J, Januszewski A, Steciwko A. Zdrojewicz Z, et al. Med Pr. 1996;47(3):217-25. Med Pr. 1996. PMID: 8760505 Polish.

9

[Proteins modified in the nonenzymatically glycosylation reaction (AGE-proteins)--new markers for diabetes?].

Zdrojewicz Z, Januszewski A, Kwiatkowska D. Zdrojewicz Z, et al. Postepy Hig Med Dosw. 1994;48(6):689-700. Postepy Hig Med Dosw. 1994. PMID: 7675730 Review. Polish.

10

[Katacalcin--structure, secretion and clinical significance].

Zdrojewicz Z, Januszewski A. Zdrojewicz Z, et al. Postepy Hig Med Dosw. 1994;48(4):371-80. Postepy Hig Med Dosw. 1994. PMID: 7638091 Review. Polish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters